Prognostic significance of cytokine levels in newly-diagnosed AML and high-risk myelodysplasia.

被引：0
|
作者：
Albitar, M [1 ]
Estey, E [1 ]
Doherty, D [1 ]
Shen, Y [1 ]
Cortes, J [1 ]
O'Brien, S [1 ]
Giles, F [1 ]
Kantarjian, H [1 ]
Kurzrock, R [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1382
引用
收藏
页码：327A / 327A
页数：1
相关论文
共 50 条
  • [1] The prognostic significance of cytokine levels in newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromes
    Tsimberidou, Apostolia Maria
    Estey, Elihu
    Wen, Sijin
    Pierce, Sherry
    Kantarjian, Hagop
    Albitar, Maher
    Kurzrock, Razelle
    CANCER, 2008, 113 (07) : 1605 - 1613
  • [2] Prognostic significance of an unsuccessful cytogenetic analysis in newly-diagnosed AML.
    RavandiKashani, F
    Hayes, K
    Lovshe, D
    Pierce, S
    Estey, E
    BLOOD, 1995, 86 (10) : 3091 - 3091
  • [3] INVESTIGATING PRETREATMENT QUALITY OF LIFE AND SYMPTOMATOLOGY IN NEWLY DIAGNOSED HIGH-RISK PATIENTS WITH MYELODYSPLASIA. GIMEMA AND EORTC QUALITY OF LIFE GROUP
    Efficace, F.
    Angelucci, E.
    Sprangers, M.
    Gaidano, G.
    Caocci, G.
    Breccia, M.
    Voso, M. T.
    Staudere, R.
    Selleslag, D.
    Luebbert, M.
    Cascavilla, N.
    Rauzy, B.
    Chonghua, W.
    Specchia, G.
    Chie, W.
    Focan, C.
    Cottone, F.
    Vignetti, M.
    Mandelli, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 187 - 187
  • [4] Advances in therapeutic options for newly diagnosed, high-risk AML patients
    Doucette, Kimberley
    Karp, Judith
    Lai, Catherine
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2021, 12 : 1 - 22
  • [5] Independent prognostic significance of day 21 cytogenetic findings in newly-diagnosed AML, RAEB-t, or RAEB.
    Konopleva, M
    Cortes, J
    Cheng, SC
    Hayes, K
    Giles, F
    O'Brien, S
    Kantarjian, H
    Andreeff, M
    Estey, E
    BLOOD, 2001, 98 (11) : 328A - 329A
  • [6] Non-myeloablative allogeneic transplantation for high-risk acute leukemia and myelodysplasia.
    Peggs, K
    Craddock, C
    Milligan, D
    Chopra, R
    Mahendra, P
    Chakraverty, R
    Hunter, A
    Parker, A
    Pettengell, R
    Vandenberghe, E
    Hale, G
    Waldmann, H
    Kottaridis, P
    Morris, E
    Goldstone, A
    Linch, D
    Mackinnon, S
    BLOOD, 2001, 98 (11) : 410A - 411A
  • [7] Prognostic significance of chromosomal genomic array testing in adults with newly-diagnosed acute lymphoblastic leukemia
    Kopmar, Noam E.
    Qu, Xiaoyu
    Liu, Yajuan
    Gooley, Ted A.
    Ghiuzeli, Cristina M.
    Mawad, Raya
    Percival, Mary-Elizabeth M.
    Fang, Min
    Cassaday, Ryan D.
    LEUKEMIA & LYMPHOMA, 2025, 66 (01) : 155 - 158
  • [8] Serum Levels of Cytokines and Cytokine Receptors Are Associated with Outcome in Newly Diagnosed AML Patients
    Kupsa, Tomas
    Vanek, Jan
    Zak, Pavel
    Jebavy, Ladislav
    Horacek, Jan M.
    BLOOD, 2016, 128 (22)
  • [9] Prognostic significance of tissue necrosis factor-alpha in newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromes
    Tsimberidou, Apostolia-Maria
    Estey, Elihu
    Albitar, Maher
    Wen, Sijin
    Brandt, Mark
    Pierce, Sherry
    Kantarjian, Hagop
    Kurzrock, Razelle
    BLOOD, 2007, 110 (11) : 133B - 133B
  • [10] CYTOKINE RECEPTORS AND SOLUBLE ADHESION MOLECULE LEVELS ARE ASSOCIATED WITH PROGNOSIS OF NEWLY DIAGNOSED AML
    Kupsa, T.
    Zak, P.
    Jebavy, L.
    Horacek, J. M.
    HAEMATOLOGICA, 2017, 102 : 377 - 377
12345